This study is in progress, not accepting new patients
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Diego, California
- Dates
- study startedcompletion around
- Principal Investigator
- by Benjamin M Heyman, MD
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at UCSD
- Benjamin M Heyman, MD
Associate Clinical Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 22 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Diego
- ID
- NCT04501939
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 5 people participating
- Last Updated